SAVOIA, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.945
AS - Asia 909
EU - Europa 674
SA - Sud America 165
Continente sconosciuto - Info sul continente non disponibili 100
AF - Africa 32
OC - Oceania 2
Totale 3.827
Nazione #
US - Stati Uniti d'America 1.865
SG - Singapore 310
CN - Cina 304
UA - Ucraina 147
IT - Italia 137
BR - Brasile 133
DE - Germania 94
FI - Finlandia 75
HK - Hong Kong 68
VN - Vietnam 64
FR - Francia 60
GB - Regno Unito 56
BD - Bangladesh 55
IN - India 38
CA - Canada 31
RU - Federazione Russa 31
TR - Turchia 24
IE - Irlanda 23
AR - Argentina 20
MX - Messico 18
PL - Polonia 10
NG - Nigeria 9
ZA - Sudafrica 8
IQ - Iraq 7
CZ - Repubblica Ceca 6
JP - Giappone 6
AT - Austria 5
IR - Iran 5
NL - Olanda 5
BE - Belgio 4
CR - Costa Rica 4
EC - Ecuador 4
EG - Egitto 4
ES - Italia 4
JM - Giamaica 4
PK - Pakistan 4
TT - Trinidad e Tobago 4
GT - Guatemala 3
ID - Indonesia 3
KR - Corea 3
LT - Lituania 3
NI - Nicaragua 3
SE - Svezia 3
SV - El Salvador 3
CH - Svizzera 2
CO - Colombia 2
GP - Guadalupe 2
MA - Marocco 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
Totale 3.729
Città #
Singapore 178
Ashburn 141
Fairfield 124
Jacksonville 107
Houston 94
Woodbridge 88
Ann Arbor 87
Chandler 82
Beijing 76
Council Bluffs 73
New York 72
San Jose 72
Hong Kong 67
Cambridge 56
Brescia 53
The Dalles 51
Princeton 45
Wilmington 45
Helsinki 42
Nanjing 37
Seattle 36
Dallas 35
Los Angeles 35
Santa Clara 32
Dearborn 30
Lauterbourg 29
Columbus 24
Dublin 23
Ho Chi Minh City 23
Munich 22
Buffalo 20
Hanoi 17
Istanbul 17
Shanghai 13
Turku 13
Milan 12
Moscow 12
São Paulo 12
Chicago 11
Lancaster 11
Nanchang 11
North Bergen 11
San Diego 11
Changsha 10
Hebei 10
Abuja 9
Des Moines 9
Phoenix 9
Warsaw 9
Jiaxing 8
Jinan 8
Kunming 8
London 8
Orem 8
Pune 8
Shenyang 8
Denver 7
Mexico City 7
San Francisco 7
Brooklyn 6
Guangzhou 6
Johannesburg 6
Leawood 6
Poplar 6
San Mateo 6
Toronto 6
Belo Horizonte 5
Boardman 5
Brasília 5
Brno 5
Charlotte 5
Montreal 5
Redondo Beach 5
San Donà Di Piave 5
Tokyo 5
Amsterdam 4
Chennai 4
Da Nang 4
Frankfurt am Main 4
Haiphong 4
Manchester 4
Tianjin 4
Turin 4
Verona 4
Waltham 4
Ardabil 3
Atlanta 3
Augusta 3
Boston 3
Brussels 3
Chaguanas 3
Chiampo 3
Cincinnati 3
Düsseldorf 3
Hangzhou 3
Kingston 3
Macerata 3
Managua 3
Naples 3
Ningbo 3
Totale 2.355
Nome #
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 222
The D3 dopamine receptor: From structural interactions to function. 200
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 186
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 185
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 181
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 177
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 175
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 160
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 153
Role of dopamine D3R and acetylcholine nicotinic receptor interaction in the regulation of dopaminergic neurons function. 143
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 134
Down-regulation of the D1R/Shp-2/Erk1/2 pathway ameliorates L-DOPA-induced dyskinesia in the 6-Hydroxy-Dopamine rat model of Parkinson's disease. 133
D1 receptor signalling in basal ganglia function and dysfunctions. 132
Role of dopamine D3R/nAChR heterodimeric complex in the regulation of dopaminergic neurons function. 129
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 127
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 121
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 120
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 120
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 118
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 117
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 115
A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis 97
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 88
Italian expert-based recommendations on the use of photo(chemo)therapy in the management of mycosis fungoides: Results of an e-Delphi consensus 81
Short-term effectiveness and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis: results from a 16-week real-world multicenter retrospective study - il AD (Italian landscape atopic dermatitis) 70
From north to south: exploring Italian sun-exposure habits through the “Save your skin” campaign 67
Short-, mid- and long-term efficacy of dupilumab in moderate-to-severe atopic dermatitis: a real-world multicentre Italian study of 2576 patients 64
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study 62
Effectiveness and safety of upadacitinib in patients with moderate-to-severe atopic dermatitis and prior inefficacy of T helper 2 biologics: a propensity score-matched study 56
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis 50
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the “Save Your Skin” Screening Campaign 44
Totale 3.827
Categoria #
all - tutte 17.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022130 0 0 0 0 0 3 13 8 9 27 18 52
2022/2023213 31 0 5 17 22 60 4 21 42 0 7 4
2023/2024234 16 5 21 24 13 70 4 5 37 7 6 26
2024/2025457 3 8 2 42 43 53 33 21 27 36 108 81
2025/20261.130 90 108 86 175 99 73 171 62 62 90 70 44
2026/2027393 71 54 90 134 44 0 0 0 0 0 0 0
Totale 3.827